Table 3.
P-value | OR (95% confidence intervals) | ||
---|---|---|---|
Model 1a | BHB | 0.004 | 1.177 (1.053–1.314) |
Model 21b | Age | <0.001 | 1.037 (1.026–1.048) |
Gender | <0.001 | 0.304 (0.240–0.386) | |
BHB | 0.007 | 1.178 (1.045–1.327) | |
Model 31c | Age | <0.001 | 1.035 (1.023–1.048) |
Gender | <0.001 | 0.417 (0.308–0.564) | |
Smoking status | |||
Never | – | – | |
Former | 0.016 | 1.689 (1.103–2.587) | |
Current | <0.001 | 2.082 (1.503–2.883) | |
Overweight/obesity | 0.102 | 0.802 (0.616–1.045) | |
Hypertension | 0.020 | 1.353 (1.048–1.746) | |
Dyslipidemia | 0.877 | 0.981 (0.774–1.245) | |
Diabetes | <0.001 | 2.570 (1.979–3.339) | |
History of stroke | 0.241 | 1.266 (0.853–1.878) | |
Family history of premature CAD | 0.011 | 1.504 (1.097–2.063) | |
BHB | 0.032 | 1.151 (1.012–1.309) |
Model 1: Crude risk.
Model 2: Adjusted for age and gender.
Model 3: Further adjusted for smoking status, obesity or overweight, hypertension, dyslipidemia, diabetes, stroke, and family history of premature CAD. For gender, smoking status, overweight/obesity, hypertension, dyslipidemia, diabetes, history of stroke, family history of premature CAD, the reference are women, never smoking, body mass index (BMI) <24 kg/m2, no hypertension, no dyslipidemia, no diabetes, no history of stroke, and no family history of premature CAD, respectively.